IP Library Granted Patent US 8,110,670
Granted Patent B2
US 8,110,670 · App. 12/278,960 · Granted Feb 7, 2012

Enhanced production of fatty acid derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,110,670
App. No.
12/278,960
Granted
Feb 7, 2012
Kind
B2
Abstract

Genetically engineered cells and microorganisms are provided that produce products from the fatty acid biosynthetic pathway (fatty acid derivatives), as well as methods of their use. The products are particularly useful as biofuels.

Claims (36)

1. A cultured recombinant cell, said cell comprising, (a) at least one gene encoding a fatty acid derivative enzyme selected from an acyl-CoA synthase (EC 2.3.1.86), a thioesterase (EC 3.1.2.- or EC 3.1.1.5), an acyl-CoA reductase (EC 1.2.1.50), a fatty alcohol forming acyl-CoA reductase (EC 1,1.1.*), and an ester synthase (EC 2.3.1.20 or EC 2.3.1.75), which gene is over-expressed, and (b) a gene encoding an acyl-CoA dehydrogenase enzyme (EC 1.3.99.3), wherein expression of the gene encoding said acyl-CoA dehydrogenase enzyme is attenuated, and wherein when cultured in the presence of a carbon source said cultured recombinant cell produces a fatty acid derivative selected from a fatty acid, a fatty aldehyde, a fatty alcohol and a fatty ester.

2. The cultured recombinant cell of claim 1 , comprising less than or equal to 50 ppm arsenic, less than or equal to 200 ppm calcium, less than or equal to 200 ppm chlorine, less than or equal to 50 ppm copper, less than or equal to 300 ppm iron, less than or equal to 50 ppm lead, less than or equal to 50 ppm manganese, less than or equal to 50 ppm magnesium, less than or equal to 0.5 ppm mercury, less than or equal to 50 ppm molybdenum, less than or equal to 2% nitrogen, less than or equal to 200 ppm potassium, less than or equal to 300 ppm sodium, less than or equal to 1 ppm sulfur, less than or equal to 1% sulfur, less than or equal to 50 ppm zinc, or less than or equal to 700 ppm phosphorus.

3. The cultured recombinant cell of claim 1 , comprising a fatty acid derivative having a double bond at position 7 in the carbon chain (between C 7 and C 8 ) from the reduced end of the fatty acid derivative.

4. The cultured recombinant cell of claim 1 , wherein the fatty acid derivatives comprises C 5 -C 25 fatty esters.

5. The cultured recombinant cell of claim 1 , wherein the fatty acid derivatives comprises straight chain or branched chain fatty acid derivatives.

6. The cultured recombinant cell of claim 1 , wherein the fatty acid derivatives produced by said cultured recombinant cell have a fraction of modern carbon of 1.003 to 1.5.

7. A fatty acid derivative composition produced by a method comprising:

(a) obtaining the recombinant cell according to claim 1 ;

(b) culturing the recombinant cell under suitable conditions for expression of the enzymes and production of a fatty acid derivative selected from the group consisting of a fatty acid, a fatty aldehyde, a fatty alcohol and a fatty ester; and

(c) producing the fatty acid derivative composition.

8. A biofuel comprising the fatty acid derivative composition of claim 7 .

9. A biofuel comprising the fatty acid derivative composition of claim 7 , selected from a fatty alcohol and a fatty ester.

10. The cultured recombinant cell of claim 1 , wherein the fatty acid derivatives produced by said cell comprise free fatty acids, wherein the percentage of free fatty acids by weight is at least 1%, at least 5%, at least 8%, at least 10%, or at least 20% of the total amount of fatty acid derivatives produced by the cultured recombinant cell.

11. The cultured recombinant cell of claim 10 , wherein (a) the percentage by weight of C 12 free fatty acids relative to the total free fatty acids is at least 5%; or (b) the percentage by weight of C 14 free fatty acids relative to the total free fatty acids is at least 20%; or (c) the percentage by weight of C 15 free fatty acids relative to the total free fatty acids is at least 1%; or (d) the percentage by weight of C 16 free fatty acids relative to the total free fatty acids is at least 20%; or (e) the percentage by weight of C 18 free fatty acids relative to the total free fatty acids is at least 15%.

12. The cultured recombinant cell of claim 1 , wherein the percentage of fatty esters produced by said cultured recombinant cell is at least 50%, at least 60%, at least 75%, at least 80%, or at least 85% by weight of the total amount of fatty acid derivatives produced by the cultured recombinant cell.

13. The cultured recombinant cell of claim 12 , wherein (a) the percentage by weight of C 12 fatty esters relative to the total fatty esters produced by said cell is at least 1%; or (b) the percentage by weight of C 14 fatty esters relative to the total fatty esters produced by said cell is at least 10%; or (c) the percentage by weight of C 16 fatty esters relative to the total fatty esters produced by said cell is at least 30%; or (d) the percentage by weight of C 18 fatty esters relative to the total fatty esters produced by said cell is at least 20%.

14. The cultured recombinant cell of claim 1 , wherein said cultured recombinant cell produces fatty esters and free fatty acids.

15. The cultured recombinant cell of claim 14 , wherein the ratio of fatty esters to free fatty acids is 10:1, 9:1, 8:1, 7:1, 5:1, 2:1 or 1.:1.

16. The composition cultured recombinant cell of claim 14 , wherein the fatty ester is at least one of: ethyl dodecanoate, ethyl tridecanoate, ethyl tetradecanoate, ethyl pentadecanoate, ethyl cis-9-hexadecenoate, ethyl hexadecanoate, ethyl heptadecanoate, ethyl cis-11-octadecenoate, ethyl octadecanoate, or a combination thereof.

17. The composition cultured recombinant cell of claim 14 , wherein the free fatty acid is at least one of: dodecanoic acid, tetradecanoic acid, pentadecanoic acid, cis-9-hexadecenoic acid, hexadecanoic acid, cis-11-octadecenoic acid, or combinations, thereof.

18. A recombinant cell culture comprising a recombinant cell, wherein one or more genes encoding a fatty acid derivative enzyme selected from a thioesterase (EC 3.1.2.- or EC 3.1.1.5), an ester synthase (EC 2.3.1.20 or EC 2.3.1.75) and an acyl-CoA synthase (EC 2.3.1.86) is over-expressed in the recombinant cell, and expression of a gene encoding an acyl-CoA dehydrogenase (EC 1.3.99.3) is attenuated in the recombinant cell, and wherein a fatty acid derivative selected from a fatty acid, a fatty aldehyde, a fatty alcohol and a fatty ester is found in the supernatant of said recombinant cell culture.

19. The recombinant cell culture of claim 18 wherein the fatty ester is produced from an alcohol and an acyl-CoA, wherein the alcohol is at least 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, 14, 16, or 18 carbons in length, and the acyl-CoA is at least 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, or 26 carbons in length.

20. The recombinant cell culture of claim 18 , wherein said fatty acid derivatives comprises a monounsaturated fatty acid derivative.

21. The recombinant cell culture of claim 20 , wherein said monounsaturated fatty acid derivative has a double bond at position 7 in the carbon chain (between C 7 and C 8 ) from the reduced end of the fatty acid derivative.

22. The recombinant cell culture of claim 18 , wherein a thioesterase (EC 3.1.2.- or EC 3.1.1.5) is over-expressed in the recombinant cell.

23. The recombinant cell culture of claim 22 , wherein one or more genes encoding an ester synthase (EC 2.3.1.20 or EC 2.3.1.75) is over-expressed in the recombinant cell.

24. The recombinant cell culture of claim 23 , wherein one or more genes encoding an acyl-CoA synthase (EC 2.3.1.86) is over-expressed in the recombinant cell.

25. The recombinant cell culture of claim 18 , wherein said fatty acid derivatives comprises a C 5 -C 25 fatty ester, a C 10 -C 20 fatty ester, or a C 12 -C 18 fatty ester.

26. The recombinant cell culture of claim 18 , wherein the recombinant cell further comprises a bkd gene encoding a branched chain alpha-keto acid dehydrogenase enzyme (EC 1.2.4.4 and/or EC2.3.1.168) and a FabH gene encoding a polypeptide having beta-ketoacyl-ACP synthase III activity (EC 2.3.1.180), and wherein the fatty acid derivatives comprise a branched chain fatty acid or a branched chain fatty alcohol.

27. A fatty acid derivative composition obtained from the supernatant of the recombinant cell culture of claim 26 , wherein the fatty acid derivative composition comprises a branched chain fatty acid or a branched chain fatty alcohol.

28. A fatty acid derivative composition comprising one or more of a fatty acid, a fatty aldehyde, a fatty alcohol and a fatty ester, obtained from the supernatant of the recombinant cell culture of claim 18 .

29. The fatty acid derivative composition of claim 28 , wherein said fatty acid derivative is a monounsaturated fatty acid derivative.

30. The fatty acid derivative composition of claim 29 , wherein said monounsaturated fatty acid derivative has a double bond at position 7 in the carbon chain (between C 7 and C 8) from the reduced end of the fatty acid derivative.

31. The fatty acid derivative composition of claim 28 , wherein one or more genes encoding an ester synthase (EC 2.3.1.20 or EC 2.3.1.35) is over-expressed in the recombinant cell.

32. The fatty acid derivative composition of claim 31 , wherein one or more genes encoding an acyl-CoA synthase (EC 2.3.1.86) is over-expressed in the recombinant cell.

33. A recombinant cell culture comprising a recombinant cell, wherein one or more genes encoding a fatty acid derivative enzyme selected from a thioesterase (EC 3.1.2.- or EC 3.1.1.5), an ester synthase (EC 2.3.1.20 or EC 2.3.1.75), an acyl-CoA reductase (EC1.2.1.50), a fatty alcohol forming acyl-CoA reductase (EC 1,1.1.*), and an acyl-CoA synthase (EC 2.3.1.86) is over-expressed in the recombinant cell, and expression of a gene encoding an acyl-CoA dehydrogenase (EC 1.3.99.3) is attenuated in the recombinant cell, and wherein a fatty acid derivative selected from a fatty acid, a fatty aldehyde, a fatty alcohol and a fatty ester is found in the supernatant of said recombinant cell culture.

Assignments (6)
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2019
From: REG LIFE SCIENCES, LLC
To: GENOMATICA, INC.
Reel/Frame 050695/0661 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SCHEDULE A, LINE 221 PREVIOUSLY RECORDED ON REEL 034193 FRAME 0175. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT APPLICATION NUMBER. Recorded Apr 7, 2015
From: LS9, INC.
To: REG LIFE SCIENCES, LLC
Reel/Frame 035391/0384 →
AMENDMENT TO PATENT ASSIGNMENT Recorded Nov 7, 2014
From: LS9, INC.
To: REG LIFE SCIENCES, LLC
Reel/Frame 034193/0175 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2009
From: HU, ZHIHAO; VALLE, FERNANDO
To: LS9, INC.
Reel/Frame 023448/0941 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2009
From: HU, ZHIHAO; VALLE, FERNANDO
To: LS9, INC.
Reel/Frame 022068/0184 →